Objective: This study compared fasting insulin and measures of insulin sensitivity based on fasting insulin and glucose (i.e., HOMA, QUICKI, FGIR) or triglycerides to the insulin clamp in a cohort of children/adolescents.
he increasing prevalence of childhood obesity, the strong association between insulin resistance and obesity, and the relation of insulin resistance to the metabolic syndrome have led to an intense clinical and research interest in the measurement of insulin resistance in children (1) (2) (3) . The "gold standard" method for measuring insulin resistance is the euglycemic-hyperinsulinemic clamp (4) , in which a constant intravenous infusion of insulin is balanced by a simultaneous infusion of glucose in a clinical research setting. Because of the invasive, time-consuming nature of the clamp procedure, it is difficult to use in routine clinical practice or large epidemiologic studies, particularly in children.
In an attempt to simplify the measurement of insulin resistance, a number of surrogate measures, based on fasting levels of insulin and glucose, (i.e. the homeostasis model assessment [HOMA] , the quantitative insulinsensitivity check index [QUICKI] , and the fasting glucose-to-insulin ratio [FGIR] ) have been developed and widely used in adult (5-7) and, subsequently, pediatric studies ). Others have used fasting insulin and triglycerides as the surrogate measures (8) . However, only two studies have directly compared these surrogate measures to insulin clamp-derived measures of insulin resistance in children and adolescents (9, 10) , and most studies have been in relatively small cohorts. Thus, there are ongoing questions about the validity of the surrogate measures and their applicability in the pediatric population.
The purpose of the present study was to compare fasting insulin (FI), HOMA, QUICKI, FGIR and [ln FI + ln triglycerides] to euglycemic insulin clamp measures of insulin resistance in a cohort of over 300 randomly selected children studied at mean age 13 and again at mean age 15 years. The results show that the surrogate measures do not offer any advantage over FI, they have only a moderate correlation to the insulin clamp, their correlation to the insulin clamp is lower in thin than heavy children, and the correlation may change with increasing age.
RESEARCH DESIGN AND METHODS
This study was approved by the University of Minnesota Committee for the Use of Human Subjects in Research. Informed consent was obtained from the parents and informed assent from the children. The subjects were participants in a longitudinal study of the relation between insulin resistance and cardiovascular risk factors in children. The original cohort was randomly recruited after blood pressure screening of Minneapolis 5 th -8 th grade public school children, as previously described (11) . From this cohort, 323 insulin clamps were completed in pubertal children (Tanner Stage II or greater) at mean age 13.1 ± 1.2 years. A second clamp was performed two years later in 300 of these participants at mean age 15.0 ± 1.2 years.
Prior to each insulin clamp , participants underwent a clinic examination and Tanner staging, as determined by pubic hair development in boys and breast and pubic hair development in girls. The greater of the two values in the girls was used in order to avoid underestimation of pubertal maturation. Height was measured with a wall-mounted stadiometer, and weight was determined using a balance scale. BMI was calculated as the weight (kg) divided by the height (meters) squared. BMI percentiles were determined using the 2000 Centers for Disease Control and Prevention (CDC) BMI-for age percentiles growth charts (12) . Triceps and subscapular skinfold thickness were measured twice to the nearest millimeter with Lange calipers, and the mean value was used to predict percentage body fat and lean body mass using the Slaughter regression equation developed specifically for this age group (13) .
T
The euglycemic hyperinsulinemic clamps have previously been described in detail (11) . Participants were admitted to the University of Minnesota Clinical Research Center after a 10-hour overnight fast. An arm vein was cannulated for infusion of potassium phosphate, insulin and dextrose, and a contralateral vein was cannulated for blood sampling with the hand placed in a heated box (65°C) to arterialize venous blood. Baseline insulin and glucose levels were determined from samples drawn at 15, 10, and 5 minutes before beginning the insulin and glucose infusions. Baseline triglycerides were determined in samples drawn 15 minutes before beginning the infusions. The insulin infusion was started at time 0 and continued at a rate of 1 mU/kg/min for 3 hours. An infusion of 20% glucose was started at time 0 and adjusted to maintain euglycemia (serum glucose level at 5.6 mmol/l) with plasma glucose determined every 5 minutes.
Plasma glucose was measured immediately at the bedside with a Beckman Glucose Analyzer II (Beckman Instruments Inc., Fullerton, CA). Insulin samples were collected on ice and centrifuged within 20 minutes.
Serum insulin levels were determined in the University of Minnesota Hospital laboratory by radioimmunoassay using a double antibody method. Triglyceride levels were determined in the same laboratory as previously described (11 Means and standard deviations (SD) were computed for the total cohort and for each BMI category (<85 th %ile and ≥85 th %ile) at each clamp at each age. Correlation coefficients in 3 forms are presented. The first is for a pair of variables (e.g., the correlation for M LBM vs. FI) in independent subgroups of people. The difference in this form of correlation was tested in a 2 sample ttest using Fisher's Z = ½ ln((1+r)/(1-r)), with variance 1/(N-3), where N is the number of persons in the analysis. The second form is for two different variables with a third common variable in a constant sample of people (e.g., correlation between M vs. FI and M LBM vs. FI). The difference in this form of correlation was tested using the method of Meng et al (14) . To compare correlations r and r in a sample of N people, calculate the difference of the Fisher's Z for r and r . The difference is tested as a t test with variance ; and f is (1-r 12 )/(2*(1-r 2 mean)), with a maximum value of 1. The third form is for the correlation between two variables measured at one time compared to the correlation between the same two variables measured at another time in a sample that is partially or completely overlapping between the two measurement times (e.g., between M vs. FI at age 13 and M vs. FI at age 15). Here we used the p-value of the regression coefficient for interaction of the first variable with time in a repeated measures regression of the repeated second variable on an intercept, an indicator for time, the repeated first variable, and the interaction mentioned above.
In an attempt to find an alternative method for assessing insulin resistance, ROC (receiver operating characteristic) curves were developed as previously described in adults (15) . The curves describe the ability of a surrogate measure to separate true positive (i.e., sensitivity) insulin resistance from false positive (i.e., specificity) at a series of cutpoints. The test accuracy is determined by the area under the ROC curve (AUC) with a value of 0.5 indicating no significant relation and a value of 1 indicating a perfect relation. In this study ROC curves were used to describe the accuracy with which levels of FI, HOMA or QUICKI can identify individuals with insulin resistance, defined as an M LBM value below the tenth percentiles of the total M LBM distribution.
RESULTS
The clinical characteristics and measures of insulin resistance at mean ages 13 and 15 are provided for the total cohort and by BMI groups in table 1. The mean fasting glucose levels for the whole cohort were 4.9±0.4 mmol/l (range 3.5-6.3 mmol/l) at mean age 13 and 4.8 ± 0.4 mmol/l (range 3.5-6.5 mmol/l) at mean age 15. The levels were not significantly different between the BMI groups at mean age 13; at mean age 15 fasting glucose was slightly, but significantly, greater in the ≥85%ile BMI group. FI levels for the whole cohort were 70.2±55.8 pmol/l (range 9-477.6 pmol/l) at mean age 13 and 72±52.8 pmol/l (range 3.6-413.4 pmol/l) at mean age 15. FI, HOMA and triglyceride levels were significantly higher while QUICKI and FGIR were significantly lower in the ≥85%ile BMI group at both ages. Insulin resistance by all three clamp measurements (M, M LBM , M LBM /ln SSI)) was significantly higher in the ≥85%ile group at age 13, but only M remained significantly higher at mean age 15. The longitudinal correlations between the surrogate values at age 13 and insulin sensitivity at age 15 were modest and varied by group. The correlations for the entire cohort ranged from 0.15 to 0.17 (p =0.006-0.1). The correlations for the ≥85%ile and <85%ile groups were within the same range (0.12-0.18), but they were not significant (p =0.9-0.25). The same pattern was seen for the correlations between the surrogates at age 13 and change in insulin sensitivity from age 13-15. In contrast, the correlations between change in the surrogate values from age 13-15 and change in insulin sensitivity from age 13-15 for the entire cohort (r =0.24-0.25), the <85%ile group (r =0.24-0.26) and the ≥85%ile group (r =0.31-0.35) all were significant (p =0.005-0.0001).
The correlations between the surrogate and clamp measures of insulin resistance are shown in Table 2 . With the exception of FGIR (0.11) at mean age 15, the correlations were significantly different from zero (<0.0001) for M, M LBM and M LBM /ln SSI at both ages. In general, the correlations were slightly higher for the girls (r =0.45-0.66) than boys (r =0.37-0.51), but the differences were statistically significant (p <0.03 for all) only at age 13. There were differences in the pattern of the correlations. In the total cohort, correlations between the surrogate measures and M LBM were significantly lower than for M and M LBM /ln SSI at age 13, with the exception of FGIR;however, at age 15 the correlations for the surrogates with M LBM /ln SSI were similar to the correlations with M LBM and significantly lower than the correlations with M.
Among the BMI subgroups, there were significantly higher correlations with M than M LBM for FI and HOMA and with M LBM /ln SSI than M LBM for all the surrogates in the <85 th %ile group at age 13. In the ≥85 th %ile group at age 15 the correlations between the surrogates and M were significantly greater than with M LBM or M LBM /ln SSI.
The correlations between surrogate measures and both M LBM and M LBM /ln SSI also changed with age. The correlations for M LBM and M LBM /ln SSI with FI, HOMA, QUICKI and FGIR in the total cohort and in the ≥85 th %ile BMI group decreased from mean age 13 to 15. In particular, the change was statistically significant for all the surrogate measures vs. M LBM /ln SSI in the total group and ≥85%ile group. In general, the correlations in the ≥85%ile group were higher than in the <85%ile group.
The ROC analysis showed there was no significant difference in the AUC among FI, HOMA and QUICKI in prediction of dichotomous insulin resistance. The AUC values (0.771, 0.770 and 0.771, respectively) indicated only a modest capability to separate true positive insulin resistance from false positive. For instance, a FI cut point of 22 µu/ml (the upper 10% for fasting insulin) identified only 12 of 32 participants in the lower 10% of M LBM (true positive), but 22 participants with M LBM above the lower 10% (false positive) also were included. The AUC results were similar when the definition for insulin resistance was increased to the lower 20% for M LBM and also were similar for both the <85%tile and ≥85%tile BMI groups.
CONCLUSIONS
This large cohort of randomly selected adolescents participating in a longitudinal study of insulin resistance offered the unique opportunity to compare surrogate measures of insulin resistance based on FI and glucose levels (FI, HOMA, QUICKI, and FGIR) and [ln triglycerides + ln FI] with the "gold standard" insulin clamp measure of insulin resistance at two separate ages. The results showed that the surrogate measures were only modestly correlated with the euglycemic insulin clamp and do not appear to offer any advantage over FI alone. This study further showed that the correlations vary with BMI, with lower correlations for M LBM than M and higher correlations in the ≥85%ile group compared to the <85 th %ile group. When SSI was added to M LBM , the correlations were greater than with M at age 13 but significantly lower than with M at age 15.
In general, HOMA is the most widely used of the surrogate measures in children. The high correlation between HOMA and FI (r = 0.99) in this study is not surprising, considering the HOMA formula (FI x fasting glucose/22.5) and the finding in adults of a 24 fold variation in FI compared to a 1.8 fold variation in fasting glucose (16) . The same was true in this study with a 1.8 fold variation in fasting glucose and a 53-fold variation in FI. Fasting glucose also is maintained within a narrow range among obese children (3) and children with abnormal glucose tolerance tests (1) .
Studies in adults have reported comparisons between FI and HOMA similar to the present study (16, 17) . The relative influences of FI and glucose would be expected to be the same in the QUICKI and FGIR equations, and both of these also were significantly correlated with FI in this study, although the r values were lower. [ln FI + ln triglycerides] also did not appear to offer any advantage over FI, with high correlations with insulin resistance at age 13 but lower correlations at age 15.
The correlations between the surrogate measures and clamp derived insulin resistance unadjusted for fatness (M) were approximately 0.5 at both ages. However, after removal of fatness from the estimate of glucose disposal (M LBM ), the correlations became lower, particularly at mean age 15. Similar differences were found in a young adult African American cohort (18) . Among the BMI subgroups, the greatest differences between M and M LBM correlations were in the ≥85 th %ile group at age 15. Fatness is omitted from the calculation of clamp derived insulin resistance (4), because most glucose uptake is localized to skeletal muscle (19) . Thus, using M rather than M LBM appears to artificially improve the relation between the clamp and surrogate measures, particularly in the fatter adolescents. It has been suggested that M LBM should be corrected for SSI levels (4). Although M LBM /ln SSI in this study increased the correlations with the surrogate measures, the effect was small relative to the correlations with M LBM .
Previous studies have compared surrogate measures to clamp-derived insulin resistance with varying results. In a cohort of 31 children age 6-11 years, primarily prepubertal and obese, similar correlations to the present study were found for HOMA (r = -0.51) and FGIR (r = 0.37) but there was a higher correlation for QUICKI (r = 0.69) (9) . In a cohort of 131 pre-pubertal and pubertal children correlations of 0.91 were found for FI, QUICKI, HOMA, and FGIR in whites and 0.86 in African Americans (10) . Others have compared surrogate measures to FSIVGTT, also with disparate results. In a small study of 18 obese children the correlations for FI, HOMA, QUICKI, and FGIR all were approximately 0.9 (20) , and in a study of 30 obese and 36 lean children the correlations with HOMA and QUICKI were <0.2 (21) . In adults, the European Group for the Study of Insulin Resistance reported a correlation of 0.37 between FI and the insulin clamp in 1140 subjects (4) and correlations of 0.41-0.53 were found between insulin resistance defined by the FSVIGTT and FI, HOMA and QUICKI (22) . It is not clear why the correlations differ among the studies, and in particular with regard to the present study, but they could be related to differences in age, pubertal status, BMI, or cohort size. We believe the results in the present cohort are accurate for pubertal adolescents because of the large cohort, selection of participants across the entire distribution of BMI and use of the "gold standard" insulin clamp.
A new finding in this study is the higher correlations in the heavier (BMI ≥85 th %ile) children. This also has been reported in adults where correlations with FI, HOMA, and QUICKI were approximately 0.35 for normal weight, 0.55 for overweight and 0.60 for obese subjects, (16) .
Although an explanation for this difference between heavy and thin individuals is not readily apparent, it may be related to the fact that an increase in BMI is most commonly related to an increase in fatness, and insulin resistance could increase at a faster than linear rate as adiposity increases. As previously discussed (16) , obesity is associated with higher levels of FI than in normal weight individuals, even when the weight groups are matched for glucose intolerance or insulin resistance. This difference in FI also was found between the ≥85%ile and <85%ile groups in the present study. It seems reasonable to suggest that higher levels of FI, representing altered insulin secretion or clearance, could influence the correlations between the surrogate measures, which are dependent on levels of FI, and the clamp. The low correlations in the <85 th %ile group suggest that the use of surrogate measures to assess insulin resistance in thin children is particularly unreliable.
The results from this study demonstrate the dilemma faced in assessing the role of insulin resistance during childhood and adolescence.
While it generally is not feasible to conduct invasive tests for insulin resistance in large cohort studies, the correlation data, graphs and ROC analyses show that FI and other surrogate measures are imprecise substitutes. This is not surprising since the clamp measures only cellular ACKNOWLEDGMENTS glucose uptake, while FI represents the integrated effect of glucose and insulin release and clearance. That is not to say that FI may not be a marker of cardiovascular risk, but only that it is a poor representation of insulin resistance. This study was supported by grants HL52851 and M01RR00400 from the National Institutes of Health. 
